Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Colorectal Neoplasms

  Free Subscription


1 Ann Surg
1 Ann Surg Oncol
2 BMC Cancer
2 Br J Cancer
1 Br J Surg
1 Cancer
2 Cancer Res
3 Clin Cancer Res
1 Dis Colon Rectum
1 Eur J Cancer
1 Eur J Gastroenterol Hepatol
1 Eur J Surg Oncol
2 Gastroenterology
1 Gut
2 Int J Cancer
13 Int J Colorectal Dis
6 J Am Coll Surg
3 Lancet Oncol
1 Oncogene
1 Oncol Rep
1 PLoS Med
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg

  1. ZHU D, Xia J, Gu Y, Lin J, et al
    Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative Colorectal Cancer Resection: A Prospective, Multi-Center, Randomized Controlled Trial.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004558.
    PubMed         Abstract available

    Ann Surg Oncol

  2. YAJIMA S, Suzuki T, Oshima Y, Shiratori F, et al
    New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study.
    Ann Surg Oncol. 2020 Nov 18. pii: 10.1245/s10434-020-09342.
    PubMed         Abstract available

    BMC Cancer

  3. CAO Y, Gu J, Yan L, Deng S, et al
    The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis.
    BMC Cancer. 2020;20:1099.
    PubMed         Abstract available

  4. SATAKE H, Ando K, Oki E, Shimokawa M, et al
    Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.
    BMC Cancer. 2020;20:1116.
    PubMed         Abstract available

    Br J Cancer

  5. HUIJBERTS SCFA, Boelens MC, Bernards R, Opdam FL, et al
    Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib.
    Br J Cancer. 2020 Nov 18. pii: 10.1038/s41416-020-01147.
    PubMed         Abstract available

  6. JACOME AA, Vreeland TJ, Johnson B, Kawaguchi Y, et al
    The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients.
    Br J Cancer. 2020 Nov 19. pii: 10.1038/s41416-020-01169.
    PubMed         Abstract available

    Br J Surg

  7. MARINO F, Trompetto M, Gallo G
    COVID-19 pandemic: a large boulder on the head of stoma patients.
    Br J Surg. 2020;107:e303.


  8. LAM TYT, Wu PI, Tang RSY, Luk AKC, et al
    Mobile messenger-initiated reminders improve longitudinal adherence in a community-based, opportunistic colorectal cancer screening program: A single-blind, crossover randomized controlled study.
    Cancer. 2020 Nov 20. doi: 10.1002/cncr.33336.
    PubMed         Abstract available

    Cancer Res

  9. HOUSLEY SN, Nardelli P, Carrasco DI, Rotterman TM, et al
    Cancer Exacerbates Chemotherapy-Induced Sensory Neuropathy.
    Cancer Res. 2020;80:2940-2955.
    PubMed         Abstract available

  10. PORTA C, Consonni FM, Morlacchi S, Sangaletti S, et al
    Tumor-Derived Prostaglandin E2 Promotes p50 NF-kappaB-Dependent Differentiation of Monocytic MDSCs.
    Cancer Res. 2020;80:2874-2888.
    PubMed         Abstract available

    Clin Cancer Res

  11. YOO SY, Park HE, Kim JH, Wen X, et al
    Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor-Immune Microenvironment in Colorectal Cancers.
    Clin Cancer Res. 2020;26:870-881.
    PubMed         Abstract available

  12. JACOBS SA, Lee JJ, George TJ, Wade JL, et al
    Neratinib plus Cetuximab in Quadruple WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study.
    Clin Cancer Res. 2020 Nov 17. pii: 1078-0432.CCR-20-1831.
    PubMed         Abstract available

  13. CAPDEVILA J, Arques O, Hernandez Mora JR, Matito J, et al
    Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas.
    Clin Cancer Res. 2020;26:902-909.
    PubMed         Abstract available

    Dis Colon Rectum

  14. KUSUNOKI K, Toiyama Y, Okugawa Y, Yamamoto A, et al
    Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients With Colorectal Cancer After Surgical Resection.
    Dis Colon Rectum. 2020;63:1242-1250.
    PubMed         Abstract available

    Eur J Cancer

  15. BOLHUIS K, Kos M, van Oijen MGH, Swijnenburg RJ, et al
    Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.
    Eur J Cancer. 2020;141:225-238.
    PubMed         Abstract available

    Eur J Gastroenterol Hepatol

  16. DI LEO M, Zuppardo RA, Puzzono M, Ditonno I, et al
    Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study.
    Eur J Gastroenterol Hepatol. 2020 Nov 17. doi: 10.1097/MEG.0000000000002000.
    PubMed         Abstract available

    Eur J Surg Oncol

  17. KONSTANTINOU I, Shapey IM, Papamichael D, de Liguori Carino N, et al
    Outcomes following potentially curative therapies for older patients with metastatic colorectal cancer.
    Eur J Surg Oncol. 2020 Nov 12. pii: S0748-7983(20)30900.
    PubMed         Abstract available


  18. CHEN H, Gao S, Liu W, Wong CC, et al
    RNA m(6)A methyltransferase METTL3 facilitates colorectal cancer by activating m(6)A-GLUT1-mTORC1 axis and is a therapeutic target.
    Gastroenterology. 2020 Nov 17. pii: S0016-5085(20)35402.
    PubMed         Abstract available

  19. SHAUKAT A, Shyne M, Mandel JS, Snover D, et al
    Colonoscopy with polypectomy reduces long-term incidence of colorectal cancer in both men and women: extended results from the Minnesota Colon Cancer Control Study.
    Gastroenterology. 2020 Nov 17. pii: S0016-5085(20)35403.


  20. SUN L, Wan A, Zhou Z, Chen D, et al
    RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer.
    Gut. 2020 Nov 20. pii: gutjnl-2020-320652. doi: 10.1136/gutjnl-2020-320652.
    PubMed         Abstract available

    Int J Cancer

  21. ZHAN T, Faehling V, Rauscher B, Betge J, et al
    Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155.
    Int J Cancer. 2020 Nov 13. doi: 10.1002/ijc.33393.

  22. DIZDAR O
    Comments on "Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database".
    Int J Cancer. 2020 Aug 15. doi: 10.1002/ijc.33258.

    Int J Colorectal Dis

  23. OLLIVIER L, Guilloit JM, Dos Santos M, Guillemette L, et al
    Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancers.
    Int J Colorectal Dis. 2020;35:559-564.
    PubMed         Abstract available

  24. SAADAT LV, Mahvi DA, Jolissaint JS, Urman RD, et al
    Discharge destination following rectal cancer resection: an analysis of preoperative and intraoperative factors.
    Int J Colorectal Dis. 2020;35:249-257.
    PubMed         Abstract available

  25. SCHOLLBACH J, Kircher S, Wiegering A, Anger F, et al
    The local immune phenotype influences prognosis in patients with nodal-positive rectal cancer after neoadjuvant chemoradiation.
    Int J Colorectal Dis. 2020;35:365-370.
    PubMed         Abstract available

  26. KASSIM SA, Abbas M, Tang W, Wu S, et al
    Retrospective study on melanosis coli as risk factor of colorectal neoplasm: a 3-year colonoscopic finding in Zhuhai Hospital, China.
    Int J Colorectal Dis. 2020;35:213-222.
    PubMed         Abstract available

  27. PARENTE P, Covelli C, Parrella P, Latiano TP, et al
    Intestinal adenosquamous carcinoma with a synchronous skin metastasis: a immunohistochemical and molecular analysis.
    Int J Colorectal Dis. 2020;35:337-341.
    PubMed         Abstract available

  28. LAMBRESCAK E, Delanian S
    Delayed septic radiation-induced calcinosis cutis long after cured anorectal cancer.
    Int J Colorectal Dis. 2020;35:333-336.
    PubMed         Abstract available

  29. LEE SH, Lim SW
    Risk factors for postoperative delirium after colorectal surgery: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2020;35:433-444.
    PubMed         Abstract available

  30. SUN B
    Endoscopic tattooing: a risk for tumor implantation.
    Int J Colorectal Dis. 2020;35:571-574.
    PubMed         Abstract available

  31. HASEGAWA H, Tsukada Y, Wakabayashi M, Nomura S, et al
    Impact of intraoperative indocyanine green fluorescence angiography on anastomotic leakage after laparoscopic sphincter-sparing surgery for malignant rectal tumors.
    Int J Colorectal Dis. 2020;35:471-480.
    PubMed         Abstract available

  32. MAGOULIOTIS DE, Tzovaras G, Diamantis A, Tasiopoulou VS, et al
    A meta-analysis of liver-first versus classical strategy for synchronous colorectal liver metastases.
    Int J Colorectal Dis. 2020;35:537-546.
    PubMed         Abstract available

  33. YANG Z, Wang XF, Yang LF, Fang C, et al
    Prevalence and risk factors for postoperative delirium in patients with colorectal carcinoma: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2020;35:547-557.
    PubMed         Abstract available

  34. BRUNNER M, Krautz C, Kersting S, Weber GF, et al
    Oncological colorectal surgery during the COVID-19pandemic-a national survey.
    Int J Colorectal Dis. 2020;35:2219-2225.
    PubMed         Abstract available

  35. KAKIZOE M, Watanabe J, Suwa Y, Nakagawa K, et al
    The histopathological evaluation based on the indocyanine green fluorescence imaging of regional lymph node metastasis of splenic flexural colon cancer by near-infrared observation.
    Int J Colorectal Dis. 2020 Nov 19. pii: 10.1007/s00384-020-03798.
    PubMed         Abstract available

    J Am Coll Surg

  36. Discussion.
    J Am Coll Surg. 2020;230:439-441.

  37. Discussion.
    J Am Coll Surg. 2020;230:582-584.

  38. Discussion.
    J Am Coll Surg. 2020;230:628-630.

  39. Discussion.
    J Am Coll Surg. 2020;230:656-658.

  40. Discussion.
    J Am Coll Surg. 2020;230:676-678.

  41. Discussion.
    J Am Coll Surg. 2020;230:698-699.

    Lancet Oncol

  42. PATEL S, Pandey D, Saklani A
    Results from the PROPHYLOCHIP-PRODIGE 15 trial.
    Lancet Oncol. 2020;21:e497.

  43. TANIS PJ, Tuynman JB, de Hingh IHJT
    Results from the PROPHYLOCHIP-PRODIGE 15 trial.
    Lancet Oncol. 2020;21:e496.

  44. GOERE D, Ducreux M
    Results from the PROPHYLOCHIP-PRODIGE 15 trial - Authors' reply.
    Lancet Oncol. 2020;21:e498.


  45. BECK M, Baranger M, Moufok-Sadoun A, Bersuder E, et al
    The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanisms.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01546.
    PubMed         Abstract available

    Oncol Rep

  46. ESPINOZA I, Agarwal S, Reddy A, Shenoy V, et al
    Expression of trefoil factor 3 is decreased in colorectal cancer.
    Oncol Rep. 2020 Oct 30. doi: 10.3892/or.2020.7829.
    PubMed         Abstract available

    PLoS Med

  47. ALI KHAN U, Fallah M, Sundquist K, Sundquist J, et al
    Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study.
    PLoS Med. 2020;17:e1003431.
    PubMed         Abstract available

    PLoS One

  48. ASADOLLAHI P, Ghanavati R, Rohani M, Razavi S, et al
    Correction: Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
    PLoS One. 2020;15:e0242387.
    PubMed         Abstract available

  49. WANG Y, Xie G, Li M, Du J, et al
    COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK/c-Jun signaling pathway.
    PLoS One. 2020;15:e0240106.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.